Cerus Corporation Depreciation & Amortization 2011-2026 | CERS

Annual Depreciation & Amortization Cerus Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.43 M	1.86 M	2.6 M	2.98 M	3.15 M	3.11 M	2.4 M	1.44 M	1.81 M	1.82 M	1.7 M	1.42 M	745 K	744 K	922 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
3.15 M	744 K	1.87 M

Quarterly Depreciation & Amortization Cerus Corporation

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
447 K	-	-	307 K	-	-	631 K	-	-	635 K	-	2.34 M	-	865 K	-	2.34 M	-	794 K	-	2.3 M	1.49 M	706 K	-	1.78 M	1.11 M	376 K	-	1.11 M	788 K	413 K	-	1.36 M	904 K	469 K	-	1.39 M	964 K	476 K	-	1.23 M	835 K	443 K	-	989 K	615 K	325 K	51 K	410 K	283 K	167 K	51 K	582 K	402 K	208 K	50 K	697 K	520 K	269 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.34 M	50 K	783 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Happiness Biotech Group Limited HAPP	380 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
AstraZeneca PLC AZN	5.73 B	-	-	$ 96.9 B	Britain
Athira Pharma ATHA	972 K	-	-	$ 269 M	USA
Galera Therapeutics GRTX	20 K	-	-32.59 %	$ 7.61 M	USA
Esperion Therapeutics ESPR	105 K	$ 3.13	-	$ 651 M	USA
Eton Pharmaceuticals ETON	4.04 M	$ 33.24	-5.01 %	$ 894 M	USA
Forte Biosciences FBRX	64 K	$ 22.01	0.02 %	$ 285 M	USA
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	4.93 M	-	-	$ 344 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Autolus Therapeutics plc AUTL	8.3 M	$ 1.75	6.06 %	$ 466 M	Britain
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Heron Therapeutics HRTX	2.31 M	$ 0.88	1.24 %	$ 147 M	USA
Cyclacel Pharmaceuticals CYCCP	5 K	-	-4.36 %	$ 27 M	USA
Compugen Ltd. CGEN	475 K	$ 2.84	8.81 %	$ 265 M	Israel
Anika Therapeutics ANIK	5.37 M	$ 14.85	-1.17 %	$ 213 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Incyte Corporation INCY	93.3 M	$ 97.05	-0.37 %	$ 18.9 B	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Ionis Pharmaceuticals IONS	10 M	$ 75.54	-0.32 %	$ 12.1 B	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 3.43	-0.29 %	$ 5.65 M	Israel
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Coherus BioSciences CHRS	1.3 M	$ 1.64	4.14 %	$ 192 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	7.72 M	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 20.78	-1.09 %	$ 2.64 B	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA